Caesarea, Israel

Labstyle Innovation Ltd.

Calculating rank
USPTO Granted Patents = 8

% Expired Patents = 12.5


Trademarks = 6

Forward Citations = 34

Loading Chart...
Loading Chart...

17 inventors (with patents filed for the assignee):

goldMedal Dov Oppenheim (4 out of 9 patents)

silverMedal Nir Lilach (3 out of 71 patents)

bronzeMedal Eliahu Eliachar (3 out of 45 patents)

4.  Ram Grossfeld (3 out of 14 patents)

5.  Frank Schenk (3 out of 7 patents)

6.  Yoav Tikochinsky (3 out of 35 patents)

7.  Oren Fuerst (3 out of 10 patents)

8.  Eyal Cohen (3 out of 22 patents)

9.  David Weintraub (3 out of 6 patents)

10.  Meir Plevinski (3 out of 3 patents)

11.  David Damshek (3 out of 4 patents)

12.  Oren Feurst (3 out of 3 patents)

13.  Eran Zur (3 out of 3 patents)

14.  Shilo Ben-Zeev (3 out of 3 patents)

15.  Haim Krief (1 out of 1 patent)


8 patents:

Company Overview
Labstyle Innovation Ltd. is a leading provider of innovative digital health products for diabetes management. Their flagship product, the Dario blood glucose monitoring system, offers a convenient and user-friendly solution for individuals living with diabetes. With a focus on precision, simplicity, and mobility, Labstyle Innovation is committed to improving the lives of those affected by diabetes through cutting-edge technology.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

8 Patents

#29 in Caesarea

#798 in Israel

Caesarea, IL
Caesarea, Israel
Forward Citations = 34

17 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Labstyle Innovation Ltd.. Retrieved from https://idiyas.com/company/labstyle-innovation

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…